跳至主要内容
临床试验/EUCTR2020-005215-46-AT
EUCTR2020-005215-46-AT进行中(未招募)1 期

Intraoperative application of nimodipine to the facial and cochlear nerves during vestibular schwannoma resection to avoid spasm-related postoperative facial paralysis and deafness - a prospective randomized study - Nimodipine Vestibularis Schwannoma

Department of Neurosurgery, Medical University of Vienna0 个研究点目标入组 30 人开始时间: 2020年11月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • patient age > 18 years
  • vestibularis schwannoma with a maximum diameter of 10-25mm on MRI
  • pre-operative audiogram
  • informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • contraindication for nimodipine application
  • vestibularis schwannoma diameter <10mm or >25mm on MRI

研究者

发起方
Department of Neurosurgery, Medical University of Vienna

相似试验